Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lorusso

Showing results (111-120 of 280) with videos related to

Pageof 28
Sort By:
Cancer Research|September 15, 1990
Antitumor efficacy of interleukin-2 alone and in combination with adriamycin and dacarbazine in murine solid tumor systemsP M LoRusso, S L Aukerman, L Polin, et al.
Oncology Nursing Forum|June 18, 2016
Qualitative Analysis of the Experience of Mental Fatigue of Family Caregivers of Patients With Cancer in Phase I TrialsDenise M Weiss, Laurel L Northouse, Sonia A Duffy, et al.
Investigational New Drugs|November 6, 2004
Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumorsBasil F El-Rayes, Dina Ibrahim, Anthony F Shields, et al.
Computer Methods and Programs in Biomedicine|March 4, 2017
Towards localization of malignant sites of asymmetry across bilateral mammogramsP Casti, A Mencattini, M Salmeri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2025
FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Dosages for First-in-Human TrialsHao Zhu, Alex N Phipps, Ying Yuan, et al.
Cancer Chemotherapy and Pharmacology|June 16, 2020
Assessment of effects of repeated oral doses of fedratinib on inhibition of cytochrome P450 activities in patients with solid tumors using a cocktail approachKen Ogasawara, Patricia M LoRusso, Anthony J Olszanski, et al.
Investigational New Drugs|May 11, 2002
Phase I clinical trial of 5-fluoro-pyrimidinone (5FP), an oral prodrug of 5-fluorouracil (5FU)Patricia M LoRusso, Sucharu Prakash, Antoinette Wozniak, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 1, 1993
Effect of estradiol on the temporal pattern of exercise-induced tissue glycogen depletion in male ratsT P Rooney, Z V Kendrick, J Carlson, et al.
Future Oncology (London, England)|May 13, 2015
A Phase I dose-escalation study of afatinib combined with nintedanib in patients with advanced solid tumorsMichael S Gordon, Gregory M Springett, Yungpo Bernard Su, et al.
Journal of the National Cancer Institute|February 16, 1994
In vivo-in vitro correlation of myelotoxicity of 9-methoxypyrazoloacridine (NSC-366140, PD115934) to myeloid and erythroid hematopoietic progenitors from human, murine, and canine marrowR E Parchment, D A Volpe, P M LoRusso, et al.
Pageof 28

Showing results (111-120 of 280) with videos related to

Sort By:
Pageof 28
Cancer Research|September 15, 1990
Antitumor efficacy of interleukin-2 alone and in combination with adriamycin and dacarbazine in murine solid tumor systemsP M LoRusso, S L Aukerman, L Polin, et al.
Oncology Nursing Forum|June 18, 2016
Qualitative Analysis of the Experience of Mental Fatigue of Family Caregivers of Patients With Cancer in Phase I TrialsDenise M Weiss, Laurel L Northouse, Sonia A Duffy, et al.
Investigational New Drugs|November 6, 2004
Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumorsBasil F El-Rayes, Dina Ibrahim, Anthony F Shields, et al.
Computer Methods and Programs in Biomedicine|March 4, 2017
Towards localization of malignant sites of asymmetry across bilateral mammogramsP Casti, A Mencattini, M Salmeri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2025
FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Dosages for First-in-Human TrialsHao Zhu, Alex N Phipps, Ying Yuan, et al.
Cancer Chemotherapy and Pharmacology|June 16, 2020
Assessment of effects of repeated oral doses of fedratinib on inhibition of cytochrome P450 activities in patients with solid tumors using a cocktail approachKen Ogasawara, Patricia M LoRusso, Anthony J Olszanski, et al.
Investigational New Drugs|May 11, 2002
Phase I clinical trial of 5-fluoro-pyrimidinone (5FP), an oral prodrug of 5-fluorouracil (5FU)Patricia M LoRusso, Sucharu Prakash, Antoinette Wozniak, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 1, 1993
Effect of estradiol on the temporal pattern of exercise-induced tissue glycogen depletion in male ratsT P Rooney, Z V Kendrick, J Carlson, et al.
Future Oncology (London, England)|May 13, 2015
A Phase I dose-escalation study of afatinib combined with nintedanib in patients with advanced solid tumorsMichael S Gordon, Gregory M Springett, Yungpo Bernard Su, et al.
Journal of the National Cancer Institute|February 16, 1994
In vivo-in vitro correlation of myelotoxicity of 9-methoxypyrazoloacridine (NSC-366140, PD115934) to myeloid and erythroid hematopoietic progenitors from human, murine, and canine marrowR E Parchment, D A Volpe, P M LoRusso, et al.
Pageof 28